Cancer in Biopsy-Proven Giant Cell Arteritis. A Population-Based Study

Seminars in Arthritis and Rheumatism

Volumn 37, Issue 3, 2007, Pages 156-163

  Gonzalez Gay, Miguel A ^a   Lopez Diaz, Maria J ^a   Martinez Lado, Luciana ^a   Peña Sagredo, Jose L ^b   Lopez Agreda, Hugo ^a   Miranda Filloy, Jose A ^a   Gonzalez Juanatey, Carlos ^a   Sanchez Andrade, Amalia ^e   Martin, Javier ^c   Llorca, Javier ^d  

^a HOSPITAL XERAL CALDE   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c CSIC   (Spain)

^d UNIVERSITY OF CANTABRIA   (Spain)

^e NONE

Author keywords

anemia; cancer; comorbidity; giant cell arteritis; inflammation; malignancy; mortality

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER; CANCER DIAGNOSIS; CLINICAL FEATURE; COLON CANCER; DISEASE ASSOCIATION; DYSPHAGIA; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HEALTH HAZARD; HUMAN; INCIDENCE; LARYNX CANCER; LEUKEMIA; LIP CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOUTH CANCER; NONHODGKIN LYMPHOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; TEMPORAL ARTERY; THYROID CANCER; TUMOR BIOPSY; UTERUS CANCER; VASCULITIS;

AGED; AGED, 80 AND OVER; BIOPSY; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; GIANT CELL ARTERITIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; NEOPLASMS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 36348972396     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2007.03.006     Document Type: Article

References (51)

1. Naschitz J.E., Rosner I., Rozenbaum M., Elias N., and Yeshurun D. Cancer-associated rheumatic disorders: clues to occult neoplasia. Semin Arthritis Rheum 24 (1995) 231-241
2. Garcia-Porrua C., and Gonzalez-Gay M.A. Cutaneous vasculitis as a paraneoplastic syndrome in adults. Arthritis Rheum 41 (1998) 1133-1135
3. Greer J.M., Longley S., Edwards N.L., Elfenbein G.J., and Panush R.S. Vasculitis associated with malignancy. Experience with 13 patients and literature review. Medicine (Baltimore) 67 (1988) 220-230
4. Hutson T.E., and Hoffman G.S. Temporal concurrence of vasculitis and cancer: a report of 12 cases. Arthritis Care Res 13 (2000) 417-423
5. Levine S.M., and Hellmann D.B. Giant cell arteritis. Curr Opin Rheumatol 14 (2002) 3-10
6. Salvarani C., Cantini F., Boiardi L., and Hunder G.G. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347 (2002) 261-271
7. Gonzalez-Gay M.A., and Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 27 (2001) 729-749
8. Gonzalez-Gay M.A., Garcia-Porrua C., Rivas M.J., Rodriguez-Ledo P., and Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 60 (2001) 367-371
9. Huston K.A., Hunder G.G., Lie J.T., Kennedy R.H., and Elveback L.R. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med 88 (1978) 162-167
10. Hellmann D.B. Temporal arteritis: a cough, toothache, and tongue infarction. JAMA 287 (2002) 2996-3000
11. Gonzalez-Gay M.A., and Garcia-Porrua C. Systemic vasculitides. Best Pract Res Clin Rheumatol 16 (2002) 833-845
12. Baldursson O., Steinsson K., Björnsson J., and Lie J.T. Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. Arthritis Rheum 37 (1994) 1007-1012
13. Boesen P., Freiesleben F., and Sorensen S. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. Arthritis Rheum 30 (1987) 294-299
14. Gran J.T., and Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-94. J Rheumatol 24 (1997) 1739-1743
15. Machado E.B., Michet C.J., Ballard D.J., Hunder G.G., Beard C.M., Chu C.P., et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum 31 (1988) 745-749
16. Salvarani C., Gabriel S.E., O′Fallon W.M., and Hunder G.G. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 123 (1995) 192-194
17. Barrier J., Pion P., Massari R., Peltier P., Rojouan J., and Grolleau J.Y. Approche épidémiologique de la maladie de Horton dans le département de Loire-Atlantique: 110 cas en 10 ans (1970-1979). Rev Med Interne 3 (1983) 13-20
18. Gonzalez-Gay M.A., and García-Porrua C. Systemic vasculitis in adults in Northwestern Spain, 1988-1997: clinical and epidemiologic aspects. Medicine (Baltimore) 78 (1999) 292-308
19. Gonzalez-Gay M.A., Miranda-Filloy J.A., Lopez-Diaz M.J., Perez-Alvarez R., Gonzalez-Juanatey C., Sanchez-Andrade A., et al. Giant cell arteritis in Northwestern Spain: a 25-year epidemiological study. Medicine (Baltimore) 86 (2007) 61-68
20. Salvarani C., Macchioni P., Zizzi F., Mantovani W., Rossi F., Castri C., et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34 (1991) 351-356
21. Sonnenblick M., Nesher G., Friedlander Y., and Rubinow A. Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol 33 (1994) 938-941
22. Hamrin B., Jonsson N., and Hellsten S. "Polymyalgia arteritica" further clinical and histopathological studies with a report of six autopsy cases. Ann Rheum Dis 27 (1968) 397-405
23. Ostberg G. Temporal arteritis in a large necropsy series. Ann Rheum Dis 30 (1971) 224-235
24. Liozon E., Loustaud V., Fauchais A.L., Soria P., Ly K., Ouattara B., et al. Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literature. J Rheumatol 33 (2006) 1606-1614
25. Haga H.J., Eide G.E., Brun J., Johansen A., and Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 20 (1993) 1335-1339
26. Myklebust G., Wilsgaard T., Jacobsen B.K., and Gran J.T. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls. J Rheumatol 29 (2002) 2143-2147
27. Gonzalez-Gay M.A. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum 33 (2004) 289-293
28. Gonzalez-Gay M.A., Barros S., Lopez-Diaz M.J., Garcia-Porrua C., Sanchez-Andrade A., and Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 84 (2005) 269-276
29. Gonzalez-Gay M.A., Garcia-Porrua C., Piñeiro A., Pego-Reigosa R., Llorca J., and Hunder G.G. Aortic aneurysm and dissection in biopsy-proven giant cell arteritis patients from Northwest Spain. A population-based study. Medicine (Baltimore) 83 (2004) 335-341
30. Lie J.T., and Members and Consultants of the American College of Rheumatology Subcommittee on classification of vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 33 (1990) 1074-1087
31. Gonzalez-Gay M.A., Garcia-Porrua C., Llorca J., Hajeer A.H., Branas F., Dababneh A., et al. Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients. Medicine (Baltimore) 79 (2000) 283-292
32. Gonzalez-Gay M.A., Garcia-Porrua C., Vazquez-Caruncho M., Dababneh A., Hajeer A., and Ollier W.E. The spectrum of polymyalgia rheumatica in Northwestern Spain: incidence and analysis of variables associated with relapse in a ten year-study. J Rheumatol 26 (1999) 1326-1332
33. Gonzalez-Gay M.A., Alonso M.D., Aguero J.J., Bal M., Fernandez-Camblor B., and Sanchez-Andrade A. Temporal Arteritis in a Northwestern Area of Spain: study of 57 biopsy proven patients. J Rheumatol 19 (1992) 277-280
34. Gonzalez-Gay M.A., Garcia-Porrua C., and Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 25 (1998) 1750-1755
35. Gonzalez-Gay M.A., Lopez-Diaz M.J., Barros S., Garcia-Porrua C., Sanchez-Andrade A., Paz-Carreira J., et al. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore) 84 (2005) 277-290
36. Gonzalez-Gay M.A. The diagnosis and management of patients with giant cell arteritis. J Rheumatol 32 (2005) 1186-1188
37. Gonzalez-Gay M.A., Blanco R., Sanchez-Andrade A., and Vazquez-Caruncho M. Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features. J Rheumatol 24 (1997) 2166-2170
38. Gonzalez-Gay M.A., Blanco R., Abraira V., Garcia-Porrua C., Ibañez D., Garcia-Pais M.J., et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 24 (1997) 2171-2176
39. Gonzalez-Gay M. The quest for the ideal therapy for giant cell arteritis. Rev Rhum Engl Ed 62 (1995) 539
40. Gonzalez-Gay M.A., Garcia-Porrua C., Amor-Dorado J.C., and Llorca J. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population. Arthritis Rheum 51 (2004) 652-655
41. Gonzalez-Gay M.A., Piñeiro A., Gomez-Gigirey A., Garcia-Porrua C., Pego-Reigosa R., Dierssen-Sotos T., et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 83 (2004) 342-347
42. Hunder G.G., Bloch D.A., Michel B.A., Stevens M.B., Arend W.P., Calabrese L.H., et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33 (1990) 1122-1128
43. Gonzalez-Gay M.A., Blanco R., and Gonzalez-Lopez M.A. Simultaneous presentation of giant cell arteritis and chronic lymphocytic leukemia. J Rheumatol 24 (1997) 407-408
44. Cid M.C., Font C., Oristrell J., de la Sierra A., Coll-Vinent B., Lopez-Soto A., et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 41 (1998) 26-32
45. Salvarani C., Cimino L., Macchioni P., Consonni D., Cantini F., Bajocchi G., et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum 53 (2005) 293-297
46. Llorca J., Lopez-Diaz M.J., Gonzalez-Juanatey C., Ollier W.E., Martin J., and Gonzalez-Gay M.A. Persistent chronic inflammation contributes to the development of cancer in patients with rheumatoid arthritis from a defined population of Northwestern Spain. Semin Arthritis Rheum (2007) Mar 13; [Epub ahead of print]
47. Gonzalez-Gay M.A. Genetic epidemiology. Giant cell arteritis and polymyalgia rheumatica. Arthritis Res 3 (2001) 154-157
48. Mattey D.L., Hajeer A.H., Dababneh A., Thomson W., Gonzalez-Gay M.A., Garcia-Porrua C., et al. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum 43 (2000) 1749-1755
49. Hajeer A.H., Dababneh A., Makki R.F., Thomson W., Poulton K., Gonzalez-Gay M.A., et al. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 55 (2000) 319-325
50. Gonzalez-Gay M.A., Amoli M.M., Garcia-Porrua C., and Ollier W.E. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 33 (2003) 38-48
51. Gonzalez-Gay M.A., Garcia-Porrua C., and Hajeer A.H. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 31 (2002) 355-360